1. All Products
  2. SOFOSBUVIR, 200mg, tab.
Public Pricelist

SOFOSBUVIR, 200mg, tab.

https://unicat.msf.org/cat/product/91541
STD DORASOFO2T-

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.4.4.2.1 - Pangenotypic direct-acting antiviral combinations
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AP08
Anatomical Therapeutic Chemical Classification according to WHOCC
S
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

SOFOSBUVIR (SOF)

Therapeutic Action

Nucleotide analogue NS5B polymerase inhibitor

Indications

Chronic hepatitis C virus (HCV), in combination with other antiviral medicines

Instructions for use

To be used in combination with daclatasvir, with or without ribavirin:

  • In children, sofosbuvir 200 mg is used in combination with daclatasvir 60 mg
  • In adults, a fixed-dose combination (FDC) of daclatasvir 60mg / sofosbuvir 400mg is available.

Storage

Below 25°C